Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

The ERSPC (European Randomized Study of Screening for Prostate Cancer) found that screening reduced prostate cancer mortality, but the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found no reduction. To evaluate whether effects of screening on prostate cancer mortality relat...

Full description

Bibliographic Details

Published in:	Annals of internal medicine Vol. 167; no. 7; p. 449
Main Authors:	Tsodikov, Alex, Gulati, Roman, Heijnsdijk, Eveline A M, Pinsky, Paul F, Moss, Sue M, Qiu, Sheng, de Carvalho, Tiago M, Hugosson, Jonas, Berg, Christine D, Auvinen, Anssi, Andriole, Gerald L, Roobol, Monique J, Crawford, E David, Nelen, Vera, Kwiatkowski, Maciej, Zappa, Marco, Luján, Marcos, Villers, Arnauld, Feuer, Eric J, de Koning, Harry J, Mariotto, Angela B, Etzioni, Ruth
Format:	Journal Article
Language:	English
Published:	United States 03.10.2017
Subjects:	Aged Early Detection of Cancer - statistics & numerical data Europe - epidemiology Humans Incidence Male Mass Screening - statistics & numerical data Middle Aged Proportional Hazards Models Prostatic Neoplasms - diagnosis Prostatic Neoplasms - epidemiology Prostatic Neoplasms - mortality Randomized Controlled Trials as Topic Time Factors United States - epidemiology
ISSN:	1539-3704, 1539-3704
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!